Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

In recent years, advances in drug therapy for head and neck squamous cell carcinoma (HNSCC) have progressed rapidly. In addition to cytotoxic anti-cancer agents such as platinum-based drug (cisplatin and carboplatin) and taxane-based drugs (docetaxel and paclitaxel), epidermal growth factor receptor...

Full description

Bibliographic Details
Main Authors: Naoya Kitamura, Shinya Sento, Yasumasa Yoshizawa, Eri Sasabe, Yasusei Kudo, Tetsuya Yamamoto
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
head and neck squamous cell carcinoma
molecular targeted therapy
cetuximab
immune checkpoint inhibitor
multi-oncogene panel test
photoimmunotherapy
Online Access:https://www.mdpi.com/1422-0067/22/1/240

Internet

https://www.mdpi.com/1422-0067/22/1/240

Similar Items